Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SAR-445877 by Sanofi for Gastric Cancer: Likelihood of Approval
SAR-445877 is under clinical development by Sanofi and currently in Phase II for Gastric Cancer. According to GlobalData, Phase II...
SAR-445877 by Sanofi for Metastatic Hepatocellular Carcinoma (HCC): Likelihood of Approval
SAR-445877 is under clinical development by Sanofi and currently in Phase II for Metastatic Hepatocellular Carcinoma (HCC). According to GlobalData,...
SAR-445877 by Sanofi for Solid Tumor: Likelihood of Approval
SAR-445877 is under clinical development by Sanofi and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
SAR-445877 by Sanofi for Non-Small Cell Lung Cancer: Likelihood of Approval
SAR-445877 is under clinical development by Sanofi and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
SAR-445877 by Sanofi for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
SAR-445877 is under clinical development by Sanofi and currently in Phase II for Adenocarcinoma Of The Gastroesophageal Junction. According to...
SAR-445877 by Sanofi for Colorectal Cancer: Likelihood of Approval
SAR-445877 is under clinical development by Sanofi and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase II...